MTSS2 and microcephaly: Patients with the MTSS2 Arg671Trp mutation exhibit a spectrum of neurodevelopmental symptoms, including global developmental delay, mild intellectual disability, ophthalmological anomalies, microcephaly or relative microcephaly, autism, and distinct facial features [3, 4].